Doug Linde
Analyst · BMO Capital Markets
Thanks, Owen. Good morning, everybody. So our last conference call was on May 3. And over the last 86 days, the conversations on the demand side of our business have really shifted from, as Owen described, return to work and space utilization to the pace of job growth and job reductions as the impacts of the Fed's actions moved their way through the economy. While leasing activity has slowed some across every market, new lease transactions that have been in documentation during the first half of the year across all of our markets and not just with our tenants continue to move towards completion. In our portfolio, none of our active lease negotiations have been scrapped. And I think that's important relative to how we have seen other dramatic slowdowns occur, where people and companies have become much more cautious about what they're doing. There is, however, less urgency with clients to make new commitments. As we consider our expectations for leasing completions in the back half of '22 and '23, we are obviously factoring in the impact of the slowdown in the macroeconomic activity, business performance and reduced overall demand for space. The availability rate defined by third-party brokers that look at the entirety of the markets continues to appear to be very elevated across virtually every office market in the country, and our markets are no exception. Last quarter, we described the work that CBRE Econometric did on the availability in the premier assets in the urban markets. Availability of space is at lower levels among premier buildings. These assets continue to get more than their proportionate share of market demand. And there are still premier building micro markets like the Back Bay in Boston or View Space in Class A buildings in San Francisco that are still performing really well, meaning rents and concessions are equal to, if not better than, pre pandemic. We have moved away from looking at the percentage of card access swipes relative to February of 2020. It seems to be talked about in the Wall Street Journal every day and are now measuring the daily and weekly utilization of seats. We've got pretty good data on daily utilization in our Boston Back Bay and New York City assets where the customer makeup is dominated by traditional financial services and professional services firms, i.e., very few technology companies. Here, we're seeing about 70% of the is being used on a weekly basis with about 50% of the employees using the space 3, 4 or 5 days a week. Now when we compare utilization from 2020 pre pandemic, the striking difference is the daily difference, where we saw 80% of the employees coming in 3 or more days a week in early 2020, 2019. There was a ramp-up, as Owen said, between March and June, but it really has plateaued as we began the summer. Some business leaders, including a few renowned technology CEOs, are becoming sterner in their message to employees regarding the importance of in-person daily activities in traditional office space. This may lead to greater daily utilization as we end the summer holiday season. We'll be able to tell you about that as we look at our September data when we talk to you in October. In the last week, we've seen announcements from some of the tech titans, Amazon, Meta, that acknowledge that they're trying to figure out how they're going to match their human capital with the utilization of physical space. Changes in the labor market supply are also going to impact these decisions. And as I said last quarter, I think this is going to be a journey when any industry expert could tell you they know how business is going to use their space or what they even think remote or hybrid work actually means in 2024 is grossly overestimating their expertise. Getting to our performance. The second quarter was a great leasing quarter for BXP. This is now the fourth straight quarter of strong overall leasing activity in our portfolio. To remind everybody, beginning with the third quarter of '21, we signed 1.4 million, 1.8 million, 1.2 million and this quarter, 1.9 million square feet of leases. So that's 6.3 million square feet of signed leases in the last 12 months. This activity has occurred in the midst of the Delta variant, the Omicron variant, remote work fits and starts and most importantly, significant labor market headwinds. As we speak to you this morning, we have signed leases on more than 975,000 square feet of in-service baked-in space that are not yet in our occupancy figures. About 50% is going to commence in '22 and the remainder in '23. At the end of the second quarter, after completing the 1.9 million square feet of active leasing, we have an additional active lease portfolio in negotiation in the in-service portfolio of 1.3 million square feet. 640,000 square feet would cover currently vacant space, so most will go into service in '23 and the other 660,000 involves currently leased space, so aka renewals or replacement tenants. Known expirations for the remainder of '22 total under 1.7 million square feet. Over the last 4 quarters, our occupancy has improved by 90 basis points and stands at 89.5% as of June 30. We expect to see a slight decline over the next few quarters as we wait for all of these signed leases to commence, but in spite of even our less robust leasing expectations, we should see occupancy pick up slightly in 2023 from today's level. The development portfolio includes 1.1 million square feet of signed leases that have yet to commence, and that excludes the lease of 290 Street. And these buildings are not included in our occupancy figures this quarter. Reston Next will be included in the in-service portfolio of '22 without the 200,000 square feet signed Volkswagen lease that won't commence until '23. We are going to see an increase in contribution from these assets even though they will show a reduction in our reported in-service occupancy. A good portion of the vacancy in our Boston suburban portfolio is now comprised of space in buildings we have actually vacated as we plan our next group of future life science conversions. When we commence redevelopment, these assets will be taken out of service. So let's talk about sort of my ranking of the markets. It goes into sort of 3 tranches. The Boston CBD stands out as the most active of our portfolio, and it is by itself in the trough tranche. And by CBD, I'm really referring to the Back Bay because that's where we have the majority of our portfolio. The New York City, Reston, Virginia really leases under 25,000 square feet; San Francisco, again, smaller tenants, leases under 25,000 square feet; and Washington, D.C. CBD make up sort of the second tranche. And then suburban Boston, South San Francisco, Mountain View, Princeton and West L.A. make up the third. Activity on the East Coast is stronger than activity on our West Coast portfolio. I think this is a function of the composition of customer demand, which has a much heavier weighting of market occupancy from traditional financial services and professional services firms on the East Coast versus technology and media companies on the West Coast. I think the big changes from the last quarter in our portfolio are the increased level of leases we're actually working on in our D.C. CBD portfolio and then the slowdown we have seen in the Boston suburbs. Now to be fair, we completed over 220,000 square feet of suburban office leasing in the suburban Boston in-service portfolio during the second quarter, where the average market rent on second-generation space was up 34%. In addition, all of the life science leases we were negotiating at 88 Winter Street were executed this quarter. We signed 3 separate leases totaling 72,000 square feet in that building, and it's now 97% leased with expected occupancy in September for the first tenant. We also signed 2 leases at 180 CityPoint, our next life science delivery totaling 140,000 square feet. So if you include the 570,000 square feet on Binney Street, we actually executed over 775,000 square feet of life science leases during the quarter in our Boston portfolio. 2021 was an extraordinary leasing year for life science, and the slowdown we are now seeing in the office leasing activity is also being felt in the life science market in our suburban Boston, suburban San Francisco and suburban Montgomery County portfolio. The biotech index, IBX, is down significantly from a year ago and fewer private companies are getting funded, which translates into a drop in active requirements relative to last year. I would note that the big pharma companies continue to have an appetite for new space in our markets. Early-stage life science tenants and their investors with an eye to slowing down their capital outflows are also pushing more of the capital spend needed to fit out space to the landlord in the form of higher TI demand. In the Boston CBD, we completed 253,000 square feet of leases. The markup on that portfolio was 18%. More than 450,000 square feet of our leases in negotiation are in the Boston CBD portfolio and that includes 200,000 square feet of retail space that has been vacant. In the San Francisco CBD, there have been a few more large tech tenants that have completed leases in sublease space, but the bulk of the activity on a direct basis has been north of market and it continues to be concentrated in the premier buildings with professional services and financial services firms. This quarter, we did 9 leases totaling 96,000 square feet in the CBD portfolio, and the leases had a second-generation increase of 37%. We also completed 2 transactions in Mountain View with an uptick of only 3%. In other positive news on the West Coast, we completed a 60,000-square-foot lease for the top 3 floors that are vacant at Safeco Plaza in Seattle. When we purchased the asset in '21, our plan included a major repositioning of the public and amenity spaces at the Fourth Avenue and Third Avenue Street plans. We have begun to introduce our repositioning plans for the building. And this, combined with our proven track record in creating great places and spaces, allowed us to win over a current BXP West Coast client to Safeco Plaza. Activity in the D.C. region was pretty light during the second quarter with the 8 office transactions totaling only 43,000 square feet and 8 retail transactions totaling 39,000. But as we look forward, we're negotiating over 270,000 square feet of leases for the in-service portfolio and 95,000 square feet of leases at 2100 Pennsylvania Avenue, our newest development in D.C. In the New York region during the quarter, the most significant transaction was a 125,000-square-foot extension at General Motors building that got signed in early April and I described last quarter. In addition, we completed another 168,000 square foot of leases across the portfolio. There were some ups and downs in the lease-to-lease rent comparison, but together, the portfolio had a slightly positive under 1% mark-to-market on the leases executed during the second quarter. We have multi-floor lease negotiations underway at 399 Park Avenue, 601 Lex, and last week, we signed a 71,000-square-foot 2-floor lease at Dock 72. Total active leases in the New York City portfolio as of July 1 was in excess of 260,000 square feet. We have had 4 consecutive strong quarters of office leasing. We have incremental development deliveries hitting in '22 that will be at their run rate in '23. We still expect occupancy improvement in '23, though at a reduced rate based on the slowdown in the economy. We continue, as Owen said, to feel really good about our portfolio position in each market. And our lack of meaningful lease expirations in '23, just over 2 million square feet, puts us in a great position entering the year. We have a strong balance sheet with low floating rate exposure and near-term maturities, so debt financing costs are going to be higher in '23. In addition to his commentary on the second quarter performance, Mike will discuss our internal interest rate expectations and our financing plans. Mike?